KD

Kyle Diamantis

Person

Heard in 6 episodes across 6 shows since Aug 2026

A U.S. Food and Drug Administration official identified in the excerpt as serving as deputy commissioner and leading the agency in an acting capacity. Public biographical information about him is limited.

Email alerts
Discussed inMarkets100%

Episodes

6
across 6 shows

This week

0
episodes on 0 shows

Expert statements

1
1 positive

Share of the conversation

Mentions of Kyle Diamantis per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.02‰0.04‰0.06‰Aug 15Sep 6Sep 29Oct 21Nov 12
Show the data
DayShare (7-day)Mentions
Aug 200.03‰1
Sep 10.01‰1
Sep 30.02‰1
Oct 160.01‰1
Nov 60.01‰1
Nov 100.03‰3

The full trend: rank, tone and why it is trending →

Email alert

Email me when Kyle Diamantis comes up on a podcast

One email a week at most, with the new episodes that mention Kyle Diamantis. Free, no account needed, unsubscribe in one click.

What others have said about Kyle Diamantis

1 statement · 1 positive

  1. Brian SkorneyPositiveNov 6, 2026· Biotech Hangout

    The FDA currently appears more stable under Kyle Diamantis.

    “the FDA feels much more stable right now under him”

    Listen at 12:01

    Open the episode · Episode 202 - November 6, 2026
Filter the statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

6 episodes featuring Kyle Diamantis, newest first